PNC FINANCIAL SERVICES GROUP, INC.

Position in NAMS — NewAmsterdam Pharma Co N.V.

CIK 713676 Pittsburgh, PA

Position in NAMS

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$247,091

-$44,807 QoQ

Shares Held

7,291

-20.0% QoQ

Ownership

0.006%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#152

of 198 holders

Holding Since

Jun 2024

9 quarters on record

Voting authority Sole 46% Shared 0% None 54%

Healthcare · as of Jun 30, 2026

PNC FINANCIAL SERVICES GROUP, INC. holds $113,274,406 across 262 Biotechnology names. NAMS ranks #50 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	69,358	$34,452,195
2	REGN	Regeneron Pharmaceuticals, Inc.	16,662	$10,389,420
3	TECH	BIO-TECHNE Corp	77,074	$5,445,277
4	MRNA	Moderna, Inc.	70,829	$4,960,151
5	TGTX	Tg Therapeutics, Inc.	89,646	$4,925,149
6	DNTH	Dianthus Therapeutics, Inc. /DE/	39,473	$3,847,827
7	INCY	Incyte Corp	32,777	$3,715,597
8	ARGX	Argenx SE	3,967	$3,680,460

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$247,091	7,291	-20.0%	Shares	Defined	2026-08-07
2026-03-31	$291,898	9,119	+147.7%	Shares	Defined	2026-05-08
2025-12-31	$129,163	3,682	+1.8%	Shares	Defined	2026-02-06
2025-09-30	$102,838	3,616	-21.3%	Shares	Defined	2025-11-07
2025-06-30	$83,195	4,594	-1.6%	Shares	Defined	2025-08-08
2025-03-31	$95,553	4,668	+6.1%	Shares	Defined	2025-05-09
2024-12-31	$113,105	4,401	-0.9%	Shares	Defined	2025-02-07
2024-09-30	$73,752	4,443	+66.2%	Shares	Defined	2024-11-08
2024-06-30	$51,367	2,674	—	Shares	Defined	2024-08-09
No filing history on record for this holder in this stock.